| Prasanth Ganesan Narahari, MD, MBBS | |
|
Us Hwy 491 North, Shiprock, NM 87420 | |
| (505) 368-6001 | |
| (505) 368-7011 |
| Full Name | Prasanth Ganesan Narahari |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | Us Hwy 491 North, Shiprock, New Mexico |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942769815 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | ME157259 (Florida) | Primary |
| Entity Name | Dhhs Phs Naihs Shiprock Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780639971 PECOS PAC ID: 0749193837 Enrollment ID: O20031105000809 |
News Archive
Scientists using machine learning - a type of artificial intelligence - with data from hundreds of children who struggle at school, identified clusters of learning difficulties which did not match the previous diagnosis the children had been given.
The Society of Interventional Radiology Foundation's Discovery Campaign, which seeks to further the growth of minimally invasive medicine into new areas of discovery, announced a major corporate pledge to that initiative. Siemens Medical Solutions, a provider of imaging and laboratory diagnostic equipment and information technology and management consulting and services to health care customers, pledged $200,000, as a "Pioneer" Supporter.
A Skoltech team has developed a model for assessing infection risks for supermarket customers. The researchers believe that their model will help formulate scientifically backed rules for safe shopping during the pandemic. The paper was published in PLOS One.
Differences in growth factor (GF) signaling may cause the poor prognosis in some breast cancer cases. A new study, published in the open access journal BMC Medical Genomics, suggests that some estrogen receptor-positive breast cancers respond poorly to tamoxifen because of increased GF signaling.
Dasatanib, a medication currently approved as treatment for drug-resistant chronic myeloid leukemia, provided patients with quicker, better responses as a first therapy than the existing front-line drug, according to researchers at The University of Texas MD Anderson Cancer Center.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Prasanth Ganesan Narahari, MD, MBBS Po Box 160, Shiprock, NM 87420-0160 Ph: (505) 368-6001 | Prasanth Ganesan Narahari, MD, MBBS Us Hwy 491 North, Shiprock, NM 87420 Ph: (505) 368-6001 |
News Archive
Scientists using machine learning - a type of artificial intelligence - with data from hundreds of children who struggle at school, identified clusters of learning difficulties which did not match the previous diagnosis the children had been given.
The Society of Interventional Radiology Foundation's Discovery Campaign, which seeks to further the growth of minimally invasive medicine into new areas of discovery, announced a major corporate pledge to that initiative. Siemens Medical Solutions, a provider of imaging and laboratory diagnostic equipment and information technology and management consulting and services to health care customers, pledged $200,000, as a "Pioneer" Supporter.
A Skoltech team has developed a model for assessing infection risks for supermarket customers. The researchers believe that their model will help formulate scientifically backed rules for safe shopping during the pandemic. The paper was published in PLOS One.
Differences in growth factor (GF) signaling may cause the poor prognosis in some breast cancer cases. A new study, published in the open access journal BMC Medical Genomics, suggests that some estrogen receptor-positive breast cancers respond poorly to tamoxifen because of increased GF signaling.
Dasatanib, a medication currently approved as treatment for drug-resistant chronic myeloid leukemia, provided patients with quicker, better responses as a first therapy than the existing front-line drug, according to researchers at The University of Texas MD Anderson Cancer Center.
› Verified 2 days ago
Sandra Beirne, MD Pediatrics Medicare: Medicare Enrolled Practice Location: Us Hwy 491 North, Shiprock, NM 87420 Phone: 505-368-7060 Fax: 505-368-6545 | |
Dr. Daniel Langsam, MD Pediatrics Medicare: Medicare Enrolled Practice Location: Hwy 491 N, Northern Navajo Medical Center, Shiprock, NM 87420 Phone: 505-368-6001 | |
Dr. Alan Lyndale Schooley, MD Pediatrics Medicare: Medicare Enrolled Practice Location: Us Hwy 491 North, Shiprock, NM 87420 Phone: 505-368-6001 Fax: 505-368-7011 | |
Tommie T Begay, MD Pediatrics Medicare: Medicare Enrolled Practice Location: Hwy 491 North, Shiprock, NM 87420 Phone: 505-368-6001 Fax: 505-368-7011 | |
Neil Gholkar, M.D Pediatrics Medicare: Medicare Enrolled Practice Location: Us Hwy 491 North, Shiprock, NM 87420 Phone: 505-368-6001 Fax: 505-368-7011 | |
Jeffrey C Powell, MD Pediatrics Medicare: Medicare Enrolled Practice Location: Us Hwy 491 North, Shiprock, NM 87420 Phone: 505-368-6401 Fax: 505-368-6431 | |
Susie A John, MD MPH Pediatrics Medicare: Medicare Enrolled Practice Location: Us Hwy 491 North, Shiprock, NM 87420 Phone: 505-368-6401 Fax: 505-368-6431 |